Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

human hepatitis B virus immune globulin

A preparation containing immunoglobulin (Igs), mainly immunoglobulin G (IgG), against hepatitis B virus (HBV), with potential immunizing and anti-viral activities. The hepatitis B IgG is isolated from donors expressing antibodies to hepatitis B-surface antigen. Upon administration of human HBV immune globulin, it may provide passive immunization against HBV, and may help prevent or treat infection by HBV.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	human HBV immune globulin
US brand name:	HepaGam HyperHep B
Foreign brand name:	Hepatect CP Zutectra

human hepatitis B virus immune globulin

Search NCI's Drug Dictionary